Regression of progestin-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors in Sprague–Dawley rats by p53 reactivation and induction of massive apoptosis: a pilot study

Indira Benakanakere(University of Missouri), Salman M. Hyder(University of Missouri)

Endocrine Related Cancer

December 16, 2008

10.1677/erc-08-0069

Cited by 14

Related Papers

Cholesterol biosynthesis inhibitor RO 48-8071 reduces progesterone receptor expression and inhibits progestin-dependent stem cell-like cell growth in hormone-dependent human breast cancer cells

|Breast Cancer Targets and Therapy|2017|7